Polo-like kinase 4 (Plk4) is a key regulator of centriole duplication, an event critical for the maintenance of genomic integrity. We show that Plk4 relocalizes from the inner Cep192 ring to the outer Cep152 ring as newly recruited Cep152 assembles around the Cep192-encircled daughter centriole. Crystal-structure analyses revealed that Cep192-and Cep152-derived peptides bind the cryptic polo box (CPB) of Plk4 in opposite orientations and in a mutually exclusive manner. The Cep152 peptide bound to the CPB markedly better than did the Cep192 peptide and effectively 'snatched' the CPB away from a preformed CPB-Cep192 peptide complex. A cancer-associated Cep152 mutation impairing the Plk4 interaction induced defects in procentriole assembly and chromosome segregation. Thus, Plk4 is intricately regulated in time and space through ordered interactions with two distinct scaffolds, Cep192 and Cep152, and a failure in this process may lead to human cancer. npg
a r t i c l e s As the principal microtubule-organizing center in mammalian cells, the centrosome has a central role in spindle formation and chromosome segregation during mitosis. Centrosomes contain two orthogonally arranged centrioles, which duplicate precisely once per cell cycle [1] [2] [3] . A failure in this process can result in abnormal centrosome numbers, improper spindle formation and chromosome missegregation that ultimately leads to genomic instability and human disorders [4] [5] [6] . Therefore, accurate control of centriole duplication is fundamentally required for normal cell division and proliferation.
Centriole duplication begins by assembling a procentriole in G1-S phase. Proper recruitment of a member of the polo kinase subfamily, Plk4, to centrosomes appears to be a key event that triggers the entire duplication process [7] [8] [9] . Interestingly, although nematodes and flies use distinct centrosomal scaffolds, Spd-2 and Asterless (Asl), respectively, to recruit their Plk4 orthologs [10] [11] [12] , humans require both Cep192 (Spd-2 ortholog) and Cep152 (Asl ortholog) for this event 13, 14 . Whether Cep192 and Cep152 function cooperatively 14 or hierarchically 13 to recruit Plk4 to centrosomes remains controversial.
In this study, we set out to investigate how the two dissimilar scaffold proteins Cep192 and Cep152 regulate Plk4 localization at subcentrosomal structures. We showed that they interact with Plk4 in a temporally and spatially regulated manner ensuring timely formation of distinct Plk4 complexes at different subcentrosomal structures. Our data suggest that ordered binding of these two scaffolds to Plk4 is critical to promote Plk4-mediated centriole biogenesis and to maintain genomic integrity.
RESULTS

Plk4 ring enlarges as Cep152 localizes to centrioles
To understand the functional relationships between Plk4 and the two Plk4-binding scaffold proteins Cep192 and Cep152 at the initial stage of centriole biogenesis, we first examined the subcentrosomal localization patterns of these proteins in U2OS cells by performing threedimensional structured illumination microscopy (3D-SIM) analysis ( Fig. 1 and Supplementary Fig. 1) .
Early in G1, Plk4 assumed a ring-like structure surrounding the proximal part of cylindrical centrioles. Interestingly, the centrioles decorated with Cep192 but not Cep152 (i.e., daughter centrioles before Cep152 recruitment) exhibited a Plk4 ring with an outer diameter of ~443 ± 34 nm, whereas the centrioles surrounded by both Cep192 and Cep152 (i.e., mother and latestage daughter centrioles) displayed a significantly larger Plk4 ring (590 ± 48 nm outer diameter) ( Fig. 1a,b and Supplementary Fig. 1b) . The sizes of these rings were in good agreement with the findings Next, we sought to structurally characterize how Plk4 CPB interacts with Cep192 and Cep152 (refs. 13,14,22,23) . We found that a minimal CPB fragment containing residues 580-808 (referred to hereafter as CPB) was sufficient for homomerization ( Supplementary Fig. 2d and details below) and that it exhibited the full capacity to interact with the two previously defined motifs, Cep192(201-280) and Cep152 13 (Supplementary Fig. 2e ). However, in disagreement with the Drosophila CPB model 20 , the PB1 of CPB did not interact with another PB1, whereas the PB2 interacted with another PB2 efficiently ( Fig. 2b) .
Our initial attempt to cocrystallize CPB with Cep192(201-280) or Cep152 failed, owing to the instability of bacterially expressed proteins. Systematic deletion analysis showed that the Cep152(1-60) fragment (hereafter Cep152-60mer) bound to CPB as efficiently as did Cep152(1-217) and coprecipitated full-length Plk4 to a degree somewhat comparable to that of full-length Cep152 ( Supplementary  Fig. 2f,g) . The Cep152-60mer exhibited no apparent homology with Cep192(201-280). However, upon reverse alignment of these two sequences, we were able to identify a Cep192(201-258) fragment (hereafter Cep192-58mer) that contains analogously positioned, predicted α-helices and D-rich motifs ( Fig. 2c) , thus hinting that the Cep192-58mer and Cep152-60mer bind to CPB in opposite orientations. Deletion of the 58mer region completely abolished the Cep192-Plk4 interaction, and the Cep192-58mer precipitated the full-length Plk4 efficiently ( Supplementary Fig. 2h,i) . These observations suggest that the Cep192-58mer is necessary and sufficient to bind to Plk4.
In vitro binding analyses showed that maltose-binding protein (MBP)-tagged Cep192-58mer bound to a CPB dimer with ~2:2 stoichiometry, whereas the MBP-Cep152-60mer bound to the latter with ~1:2 stoichiometry ( Fig. 2d) . In line with these findings, Cep192 was less effective than Cep152 in coprecipitating Plk4 from transfected HEK293T cells ( Fig. 2e) . (Assessment of the binding stoichiometry 
Cep192
Plk4 GL CEP152 siRNA: Figure 1 Two distinct Plk4 ring structures form in the absence or presence of the Cep152 ring around Cep192-decorated centrioles. (a) 3D-SIM images of asynchronously growing U2OS cells stained with the following antibodies: magenta, Alexa 647-conjugated anti-Cep192 N-terminal region (N); green, Alexa 488-conjugated anti-Cep152 middle region (M); red, anti-Plk4; blue, anti-Sas6 (pseudocolored in gray). Arrows in first row indicate the outer diameters of two Plk4 rings from daughter (D) and mother (M) centrioles (before and after Cep152 recruitment, respectively). Brackets in second row indicate Plk4 signals colocalized with a nascent Cep152 toroid assembling at a daughter centriole. Arrowheads in third and fourth rows indicate dot-like Plk4 signals colocalized with Sas6 on Cep152 toroids. Scale bar, 0.5 µm. (b) Quantification of signals in the samples in Figure 1a , showing the outer diameters of Cep192, Cep152 and Plk4 ring. G1 centrioles before or after Cep152 recruitment (n = 25 or 69, respectively) or S centrioles without discernible Plk4 ring signals (n = 41) were measured; error bars, s.d. (c) Immunoblot showing U2OS cells silenced for control luciferase (GL siRNA) or Cep152 (CEP152 siRNA). Asterisk, cross-reacting protein. (d,e) Immunostaining (d) of the cells in c and subsequent quantification (e) from three independent experiments (n = 105 for GL siRNA; n = 116 for CEP152 siRNA). Arrows in d indicate outer diameters of Cep192 and Plk4 rings; scale bar in d, 0.5 µm; error bars in e, s.d. An uncropped blot image for c is shown in Supplementary Figure 8a. a r t i c l e s for this result was not possible because of the different molecular sizes of Cep192 and Cep152.)
Structure of apo-CPB, CPB-Cep192-58mer and CPB-Cep152-60mer
Next, we determined the crystal structures of human apo-CPB and CPB complexed with Cep192-58mer or Cep152-60mer by molecular replacement (Online Methods) ( Table 1) . Like the Drosophila CPB 20 , human CPB was composed of two PB domains, PB1(580-700) and PB2(701-808), each containing an α-helix and a six-or sevenstranded antiparallel β-sheet ( Supplementary Fig. 3a) . The PB1 and PB2 domains were connected by a two-residue linker (S700 and P701). Distinctly from the Drosophila CPB proposed to form a 'donut-shaped' homodimer with both PB1-PB1 and PB2-PB2 contacts, all human CPB structures presented here contained an X-shaped homodimer with a symmetrical PB2-PB2 interface, although their crystal lattices differed from one another. We verified this dimeric interaction by a coimmunoprecipitation assay ( Fig. 2b) . Furthermore, the PB2-PB2 interface has also been observed in the Drosophila CPB structure (PDB 4G7N), but a different symmetry mate was chosen to form the donutshaped CPB dimer 20 . It was impossible to fit the human CPB structure into the Drosophila CPB model 20 (Supplementary Fig. 3b) .
The X-shaped CPB dimer was generated by a noncrystallographic dyad axis and fastened by four hydrogen bonds between two antiparallel β13 strands, one from each subunit, resulting in the formation of a continuous 14-stranded antiparallel β-sheet. The dimer interface was strengthened by multiple hydrophobic interactions between the two β13 strands and also the two α2 helices. The PB1 domains formed two wings that do not directly interact with each other (Supplementary Fig. 3a) .
In the complexes, both the Cep192-58mer and Cep152-60mer bound to the concave surface of CPB along the α1 of PB1 and over the α1-β7 junction ( Fig. 2f,g) , inducing slight alterations in the CPB structure ( Supplementary Fig. 3c ). Remarkably, the 58mer and npg a r t i c l e s 60mer peptides were oriented in opposite directions, which reflect the reverse sequence alignment of the two peptides ( Fig. 2c) . In addition, one Cep192-58mer bound to each subunit of a CPB dimer, generating a symmetrical 2:2 heterotetrameric complex ( Fig. 2f) , whereas one Cep152-60mer bound to each CPB dimer, forming a 1:2 heterotrimeric complex ( Fig. 2g and details below). Unlike Plk1 PBD, which interacts with a phosphorylated peptide through the β1 of PB1 and also partly the β8 and β9 of PB2 (ref. 24) , Plk4 CPB interacted with its target primarily through the α1 and β1 of PB1 and the β7 of PB2 ( Supplementary Fig. 3d ), requiring no phosphorylated epitope.
Structure of CPB-Cep192-58mer versus CPB-Cep152-60mer
The Cep192-58mer and Cep152-60mer formed three major contacts with the CPB. Although the centrally located α-helical sequences from the 58mer and the 60mer exhibit no detectable sequence homology ( Fig. 2c) , they bound to an overlapped region of CPB by engaging in multiple hydrophobic and hydrogen bond interactions with several common residues along the α1 and β1 of PB1 (Fig. 3a,b and details in Supplementary Fig. 3e ). The 58mer α-helix was skewed at an oblique angle to the axis of the CPB α1, whereas the 60mer α-helix was antiparallel to the CPB α1, thus forming tightly packed hydrophobic interactions between the two α-helices. The coiled-coil interface was reinforced by salt bridges between D20 and D23 of the 60mer and K711 of the CPB (Fig. 3b) .
In addition, the D-rich motif at the N terminus of the Cep192-58mer or the C terminus of the Cep152-60mer interacted with a lysine/arginine-enriched crater formed by one arginine and five lysine residues at the tip of the PB1 domain ( Fig. 3a,b and details in Supplementary Fig. 3f,g) . Among the crater-forming residues, the side chain of R684 shifted in different directions upon binding either the Cep192-58mer or Cep152-60mer ( Supplementary  Fig. 3c ). The K685 residue, centrally located in the crater, appeared to have a key role in binding the D-rich motif ( Fig. 3a,b) . Notably, the D-rich motifs exhibited a weak electron density, thus suggesting that their charge-charge interactions with the lysine/ arginine crater were diffused in a cloud-like manner instead of corresponding one to one (Supplementary Fig. 3g) . A hydrophobic residue present in the middle of the D stretch of the 58mer and 60mer (I217 and L42, respectively) fit well in the hydrophobic pocket at the center of the lysine/arginine crater (Fig. 3a,b and details in Supplementary Fig. 3f ). The D-rich motif of the 58mer efficiently neutralized the charge potential of the lysine/ arginine crater, whereas that of the 60mer, which contains fewer acidic residues, negated the charge potential less effectively ( Supplementary Fig. 3g ).
Finally, a unique acidic sequence at the N terminus of the Cep152-60mer (from E15 to E21) appeared to efficiently counteract the positive charge potential near the CPB dimeric interface (i.e., the PB2interface basic patch). This charge-charge attraction again occurred through group interactions with poorly defined electron densities for individual side chains. In the CPB-Cep192-58mer complex, the neutralizing effect was achieved by the negative helical dipoles of two 58mer peptides coming together near the CPB dimeric interface (Supplementary Fig. 3h) .
Consistently with the structural results above, mutational analyses showed that R684 in the lysine/arginine crater was vital for Cep192-58mer binding but not for Cep152-60mer binding, whereas K711, located near the dimeric interface, was crucial for Cep152-60mer binding but was much less so for Cep192-58mer binding ( Fig. 3c,d) . Interestingly, K685 of PB1 was required for binding to both the Cep192-58mer and Cep152-60mer ( Fig. 3c,d) . This may be due to its dual roles-one in the intramolecular interaction with E635 of PB1 and the other in the intermolecular electrostatic interaction with the D-rich-motif residues of the Cep192-58mer and Cep152-60mer ( Supplementary Fig. 3f ).
Significance of the Cep152 E21K mutation in human cancers
Plk4 haploinsufficiency has been shown to cause mitotic abnormalities, including chromosome mis-segregation, which can lead to spontaneous generation of cancers in mice 25 . Proper interaction of Plk4 with Cep192 and Cep152 is likely to be critical for regulating Plk4 function in centriole duplication and mitotic progression 13, 14 . A search of human mutation databases found the Cep152 E21K mutation identified in two out of 212 cases of colon and rectum adenocarcinoma (Catalogue of Somatic Mutations in Cancer, http://www.sanger. ac.uk/cosmic/); however, the same searches did not uncover any cases involving the Cep192 mutation. The Cep152-60mer E21 located near the N terminus of its α-helix may neutralize the positively charged potential of both its own helical dipole moment and the CPB surface ( Fig. 3b) . We predicted that reversal of charges in the E-to-K mutation would destabilize the α-helix and therefore the interaction of Cep152 with CPB. Indeed, the E21K mutation greatly impaired the Cep152-Plk4 interaction (Fig. 3e) . Consequently, Cep152 RNA interference (RNAi) in cells expressing a short interfering RNA (siRNA)-insensitive mutant (Cep152-sil E21K) induced a severe defect in the recruitment of Sas6 ( Fig. 3f and Supplementary Fig. 4a,b) , an event critical for procentriole assembly. The E21K mutant cells also exhibited significantly increased levels of misaligned and lagging chromosomes ( Fig. 3g and Supplementary Fig. 4c ). npg a r t i c l e s
Disruption of the CPB-Cep192-58mer complex by the Cep152-60mer
Discrete enlargement of Plk4 ring structures on Cep152-recruited centrioles ( Fig. 1a) and similar binding modes of the Cep192-58mer and Cep152-60mer to CPB (Fig. 2f,g) suggest that Cep192-Plk4 and Cep152-Plk4 complexes may not coexist in vivo. Indeed, superposition of CPB-bound Cep192-58mer and Cep152-60mer (r.m.s. deviation of 2.2 Å across all Cα atoms of the CPB dimer) showed that the Cep152-60mer not only directly interfered with the binding of Cep192-58mer to the same CPB subunit but also clashed with the second Cep192-58mer bound to the other CPB subunit (Fig. 4a) , thus suggesting that binding of the Cep192-58mer and of the Cep152-60mer to CPB is mutually exclusive.
To directly investigate the incompatible nature of these bindings to CPB, we performed a fluorescence polarization (FP) binding Figure 3 Binding modes of Cep192-58mer and Cep152-60mer to Plk4 CPB and mutational analyses of residues critical for the interaction. (a,b) Electrostatic surface representation of the CPB-Cep192-58mer (a) and the CPB-Cep152-60mer (b) complexes. The K711 and lysine/ arginine-crater residues of CPB and the E21 of Cep152-60mer are highlighted in rectangles (details in Supplementary Fig. 3e-h) .
(c-e) Immunoprecipitation (IP) analyses of HEK293T cells cotransfected with the indicated constructs. Minus, control vector; numbers, relative signal intensities. WT, wild type. (f,g) Characterization of a cancer-associated Cep152 E21K mutation. U2OS cells stably expressing either control vector or siRNA-resistant Cep152-sil or Cep152-sil E21K mutant were silenced with siRNAs targeting either luciferase (GL siRNA) or Cep152 (CEP152 siRNA) (Supplementary Table 2 ) and then immunostained with anti-Cep152 and anti-Sas6 antibodies ( Supplementary Fig. 4a-c) . Three independent experiments were carried out to quantify the numbers of centrosomal Sas6 signals (from 0 to ≥3) among interphase cells (n = 600 for each cell line) (f) and the percentage of mitotic cells (n = 600 for each cell line) with mis-segregating chromosomes (chr.) (g). Error bars, s.d. Uncropped blot images for c-e are shown in Supplementary Figure 8c a r t i c l e s assay, using Alexa 488-conjugated MBP-Cep192-58mer and MBP-Cep152-60mer. Results showed that the CPB binding affinity of the Cep152-60mer (K d = 32 ± 4 nM) was ~5.5-fold higher than that of the Cep192-58mer (K d = 177 ± 23 nM) ( Fig. 4b) .
Consistently with these results, the Cep152-60mer efficiently disrupted a preformed complex between Alexa 488-conjugated MBP-Cep192-58mer and CPB (half-maximal inhibitory concentration = 64 ± 4 nM). In a reverse experiment, Cep192-58mer, even at a concentration of up to an order of magnitude higher, failed to noticeably dissociate Alexa 488-conjugated MBP-Cep152-60mer from CPB (Fig. 4c; Online Methods) .
In an experiment using an Ni-NTA-immobilized hexahistidine (His 6 )-MBP-Cep192-58mer-CPB complex, MBP-Cep152-60mer efficiently snatched the CPB away from the preformed complex with ~1:2 stoichiometry (Fig. 4d , CPB/MBP-Cep152-60mer ratios before MBP-Cep152-60mer saturation). Consistently with this finding, the MBP-Cep152-60mer also outcompeted MBP variant (MBP L )-tagged Cep192-58mer in binding to CPB in size-exclusion chromatography (Supplementary Fig. 5a ). We obtained a similar result when we incubated Cep192(201-280) and Cep152(1-217) containing their entire Plk4-binding motifs 13 with a Plk4 C-terminal(580-970) fragment (Supplementary Fig. 5b) . These in vitro binding results were corroborated by the observation that, in transfected HEK293T cells, Cep152 was able to efficiently outcompete Cep192 in binding to Plk4 but not vice versa (Supplementary Fig. 5c,d) . Collectively, these data demonstrate that Cep192 and Cep152 are not compatible in binding to Plk4 and suggest that a free form of Cep152 is able to take Plk4 away from the preformed Cep192-Plk4 complex at daughter centrioles.
DISCUSSION
Characteristics of Plk4 CPB binding
Our results demonstrated that CPB uses its PB1 α1 flanking region, lysine/arginine crater and dimeric-interface basic patch to interact with the Cep192-58mer and Cep152-60mer, suggesting that the molecular architecture underlying the formation of these complexes is largely similar. However, the opposite orientations of the bound peptides and the differential usages of these binding sites suggest that the CPB may function as a versatile binding module that can interact with diverse cellular targets and mediate distinct cellular processes. Moreover, each target's unique binding mode may serve as the molecular basis for establishing hierarchical interactions between targets functioning in the same pathway.
It should be noted that, unlike the PBDs from Plks 1-3, Plk4 CPB did not require a phosphorylated epitope for binding. Moreover, the CPB failed to interact with its C-terminal PB3 (residues 854-970), which appeared to have only a weak capacity to form a homodimeric PB3-PB3 complex 19 (Supplementary Fig. 2d ). Whether Plk4 PB3 binds to its own target and how it functions in conjunction with its CPB have yet to be studied.
Molecular basis of unidirectional scaffold switching
We showed that Cep152 recruitment induces Plk4 relocation from the outer edge of the Cep192 ring to that of the Cep152 ring ( Fig. 1) , suggesting that Plk4 translocates unidirectionally from the Cep192 scaffold to the Cep152 scaffold. In support of this interpretation, the Cep152-60mer was able to efficiently snatch the CPB from the Cep192-58mer-CPB complex (Figs. 4d and 5) .
The mechanism underlying this unidirectional cellular process appears to stem from the different binding natures of the Cep192-58mer versus the Cep152-60mer to Plk4 CPB. Although the physiological binding stoichiometry for endogenous proteins is yet to be determined, the Cep192-58mer bound to the CPB with 2:2 stoichiometry, whereas the Cep152-60mer bound to the latter with 1:2 stoichiometry (Fig. 2d) . This is because the C termini of two Cep192-58mers engaged in heterotetrameric junctional interactions ( Supplementary  Fig. 5e) , whereas the N-terminal Cα backbone (for example, Cα of E15-D20) of the Cep152-60mer that is bound to one of the two subunits extended beyond the PB2-PB2 dimeric junction and interacted with the basic-patch residues in the other subunit ( Supplementary  Fig. 5f ). This extended binding would prevent another Cep152-60mer from binding to the second subunit (Supplementary Fig. 5g) .
So then how can the binding of one Cep152-60mer dislodge two Cep192-58mers interacting with both subunits of the CPB dimer? First, in vitro biochemical analysis showed that the 60mer binds to CPB with ~5.5-fold-higher affinity than does the 58mer. Second, superimposing the CPB-bound Cep192-58mer with the Cep152-60mer revealed that the extended N terminus of the 60mer directly interferes with the binding of the C-terminal helix region of the 58mer to the other CPB subunit (Fig. 4a) . Third, deletion of a portion of the 58mer α-helix extending toward the CPB β7 and β13 eliminated the ability of the 58mer to bind to CPB (Supplementary Fig. 5h) , thus suggesting that the steric clash between the N-terminal region of the 60mer and the C-terminal α-helix of the 58mer is sufficient to dislodge the 58mer from the CPB dimer. Intriguingly, the binding of the 58mer and 60mer to CPB occurs in opposite orientations. This reverse binding mode may help avoid the steric hindrance that could arise if the two bulky Cep192 and Cep152 proteins were to attempt to bind to Plk4 from the same direction. Figure 5 Schematic diagram illustrating the mechanism of how Cep152 snatches Plk4 away from the Cep192-Plk4 complex and repositions Plk4 at the outer boundary of a newly forming Cep152 ring structure. Early G1 daughter centrioles are decorated with a cylindrical Cep192 structure in which the N terminus of Cep192 points outward ( Supplementary  Fig. 1a ). At this stage, Plk4 forms a smaller (~440-nm outer diameter) ring through the interaction with the N-terminal region of Cep192 ( Supplementary Fig. 1 ). As Cep152 is being recruited to this location in late G1, Cep152 stochastically interacts with the Cep192-bound Plk4 and takes the Plk4 away from the Cep192 scaffold (scaffold switching). Subsequent assembly of a Cep152 ring around the Cep192 toroid in an N terminus-outward fashion prompts the repositioning of Plk4 to the outer edge of the Cep152 ring, thus resulting in a Plk4 ring structure much larger in diameter (~600 nm). Around the time of procentriole formation, Plk4 assumes a dot-like signal at the future procentriole assembly site and recruits Sas6 to this site to induce centriole biogenesis. Our earlier studies have shown that two human centrosomal scaffolds, Cep192 and Cep152, do not appreciably interact with each other and that the impairment of either of the Cep192-and Cep152-dependent Plk4 interactions is sufficient to induce a defect in Sas6 recruitment to the procentriole assembly site 13 . These findings suggest that Cep192 and Cep152 form two biochemically distinct and functionally nonredundant complexes with Plk4 and that both complexes are required to promote Plk4-mediated centriole biogenesis. In support of this view, depletion of Cep63 (ref. 26 ) disrupted Cep152 localization to centrioles but did not appear to alter Cep192 localization to this site (Supplementary Fig. 6a-c) .
Here we elucidated the molecular mechanism showing how Cep152 snatches Plk4 away from the Cep192-Plk4 complex and, as a result, repositions Plk4 at the outer edge of a newly forming Cep152 ring (Fig. 5) . As expected if the recruitment of the high-affinity Cep152 scaffold were to cause Plk4 to relocate to the outer rim of the Cep152 ring, depletion of Cep152 permitted Plk4 to reassociate with the inner Cep192 ring structure ( Fig. 1c-e ). Furthermore, when Plk4 was overexpressed, excess Plk4 was additionally localized along the entire length of the Cep192 structure ( Supplementary Fig. 6d-g) . These data suggest that Cep192 and Cep152 intricately regulate subcentrosomal localization of Plk4.
It should be noted, however, that unlike humans, nematodes use Spd-2 (Cep192 ortholog) to recruit Zyg-1 (Plk4 homolog) to centrosomes 7 , whereas flies resort to Asl (Cep152 ortholog) to recruit Plk4 (refs. 12,27) . These apparent differences hint that nematodes and flies have lost the ability of one or the other of the two scaffolds to promote Plk4 functions when evolved from their most recent common ancestor, whereas humans have kept the function of both scaffolds to cope with complex centrosomal assembly processes.
Then, what advantage is gained in humans by having two scaffolds, Cep192 and Cep152, binding to Plk4 in an ordered manner? One possibility is that, by binding to Plk4, these two scaffolds modulate Plk4 function differently at distinct stages of early G1 phase. We found that Plk4-bound Cep152, but not Plk4-bound Cep192, efficiently interacted with Cep135 ( Supplementary Fig. 7a ), a downstream component critical for procentriole assembly 28, 29 . Thus, the binding of Cep152 to Plk4 is likely to allow Plk4 to form a biologically active complex with downstream effectors, such as Cep135, and to induce procentriole assembly with other components critical for this process. Another possibility is that, because overexpression of Plk4 induces centriole overduplication 9, 30 , the binding of Cep192 to Plk4 may be important in sequestering Plk4 and preventing it from inducing unscheduled centriole duplication until Cep152 is recruited to early G1 centrioles. Notably, binding of Cep192 or Cep152 to Plk4 did not appreciably influence the Plk4 kinase activity ( Supplementary  Fig. 7b) . Thus, these two scaffold proteins modulate Plk4-dependent centriole biogenesis by altering its bound states rather than its catalytic activity.
Here we showed that two centrosomal scaffold proteins, Cep192 and Cep152, interact with Plk4 in a temporally and spatially regulated manner, thus ensuring timely formation of distinct Plk4 complexes at different subcentrosomal structures. In this regard, it is notable that the Cep152 E21K mutation found in human cancers crippled the Cep152-Plk4 interaction that led to a defect in procentriole assembly and chromosome segregation (Fig. 3e-g and Supplementary Fig. 4a-c) . We also observed similar defects with another cancer-associated, Plk4binding-defective mutant, Cep152 V8A (Supplementary Fig. 4d-h) . These findings highlight the importance of converting Plk4 from a Cep192-tethered state (sequestered state) to a Cep152-bound state (procentriole assembly state) to properly regulate centriole duplication and mitotic progression.
Scaffold proteins have diverse roles in various biological processes, such as insulating or tethering signaling components. However, in contrast to these somewhat passive roles, the two functionally distinct scaffolds that we described here operate in an opposite manner to shift a common binding target from one state to another and modulate its biological function. Incompatible binding modes and differential binding affinities are the basis of unidirectional scaffold switching that may serve as a new paradigm for understanding intricately regulated assembly processes involving multiple scaffold proteins.
METhODS
Methods and any associated references are available in the online version of the paper.
Accession codes.
Coordinates and structure factors have been deposited in the Protein Data Bank under accession codes 4N9J (apo-CPB), 4N7Z (CPB-Cep192-58mer complex) and 4N7V (CPB-Cep152-60mer complex).
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METhODS
Plasmid construction. Details for all constructs used in this work are provided in the Supplementary Note.
Cell culture and transfection. U2OS and HEK293T cells were cultured as recommended by American Type Culture Collection. Transfection was carried out with either Lipofectamine 2000 (Invitrogen) for protein overexpression or Lipofectamine RNAiMAX (Invitrogen) for siRNA transfection. U2OS cells were transfected twice with siRNA against control luciferase (GL siRNA) or Cep152 (CEP152 siRNA) for 96 h. To arrest cells in S or M phase, cells were treated with thymidine (Thy) or nocodazole (Noc) for 20 h, respectively.
Lentivirus production and generation of stable cell lines. Lentiviruses expressing siRNA-insensitive Cep152-sil, Cep152-sil E21K or Cep152-sil V8A were generated by cotransfection of HEK293T cells with pHR′-CMV∆R8.2∆vpr, pHR′-CMV-VSV-G (protein G of vesicular stomatitis virus), and pHR′-CMV-SV-puro-based Cep152-sil WT, E21K or V8A mutant with the CaCl 2 transfection method as described previously 31 . Stable U2OS cell lines expressing the gene of interest were generated by lentivirus infection and subsequent selection with 2 µg/ml of puromycin (Sigma). The resulting cells were then transfected two times with the indicated siRNA to deplete the RNAi-sensitive endogenous protein (details in Supplementary Fig. 4a,e ). All the siRNAs used in this study are listed in Supplementary Table 2 .
Antibodies. All the antibodies used in this study are summarized in Supplementary Table 1 . A rabbit polyclonal Cep192(2240-2538) antibody was generated against bacterially expressed His 6 -Cep192(2240-2538) at Young In Frontier Co., Ltd. (Seoul) and then affinity-purified with GST-Cep192(2240-2538) immobilized to Affi-gel 15 (Bio-Rad). Antibodies for Cep192 N(1-500), Cep152 M(491-810) and Plk4(580-970) were previously described 13 . The polyclonal Plk4 p-S305 antibody was generated by immunization of rabbits with a synthetic peptide, NH 2 -SSSTSISGpSLFDKRRLL-NH 2 (amino acids 297-313 in human Plk4; bold pS indicates the phospho-S305 residue) (Young In Frontier Co., Ltd., Seoul). The p-S305 antibody was then affinity-purified before use. Other primary antibodies were purchased from outside sources. Supplementary Table 1 provides additional information about the antibodies used in this study, including sources and experimental amounts used. Validations for commercial and newly generated antibodies are available on the manufacturers' websites and in Supplementary Figure 8 .
Immunostaining. Asynchronously growing U2OS cells were fixed with 4% paraformaldehyde and immunostained as described previously 32 with the indicated antibodies. Alexa Fluor-conjugated rabbit Cep192 and Cep152 antibodies were generated with Alexa Fluor labeling kits (Invitrogen). Where indicated, these antibodies were used to avoid cross-reactivities among more than two rabbit antibodies. Stained coverslips were mounted with a nonpolymerizing mounting medium from Vector Laboratories.
For images in Figure 1a , cells were first stained with rabbit anti-Plk4 and mouse anti-Sas6 antibodies. After these stainings were completed, the resulting samples were then additionally stained with Alexa 647-conjugated Cep192 N-terminal (N) and Alexa 488-conjugated Cep152 middle region (M) antibodies. For images in Supplementary Figure 1a , Alexa 488-conjugated Cep192 N-terminal (N) and Alexa 647-conjugated Cep192 C-terminal (C) antibodies were used.
Three-dimensional structured illumination microscopy (3D-SIM). Structured illumination microscopy (SIM) was performed on an ELYRA PS.1 microscope from Carl Zeiss Microscopy. Images were observed through a 63×/1.4NA objective and recorded with an Andor iXon 885 EMCCD (1,024 × 1,024 pixels, 8 × 8 µm pixel size, 65% QE), for a maximum field of view of 80 × 80 µm of the sample. Structured illumination raw data sets were acquired by projecting grids onto the sample generated from the interference of the zeroth and ± first diffraction orders from a phase grating. For the 405, 488, 561 and 642 nm excitation, phase gratings of spacing 23, 28, 34 and 34 µm (respectively) were used to generate illumination grids for maximum resolution improvement of each color. Each super-resolved image required five grid shifts (phases) and three grid rotations for a total of 15 images per super-resolved z plane per color. The ELYRA PS.1 system's maximum laser output was 50, 200, 200 and 150 mW (respectively), with a dedicated ND filter wheel for each laser for fine power control. During acquisition, laser power, camera exposure time and camera gain were adjusted so that high-contrast images (50% camera dynamic range, 16 bit) were acquired. For most images, a camera exposure time of 50 ms was used. To measure the diameter of ring signals, acquired images were analyzed with Zeiss Zen software.
Immunoprecipitation and immunoblotting analyses. Immunoprecipitation was performed essentially as described previously 32 in TBSN buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.5% Nonidet P-40, 5 mM EGTA, 1.5 mM EDTA, 20 mM p-nitrophenylphosphate and protease inhibitor cocktail (Roche)). Immunoblotting was performed according to standard procedures, and immobilized proteins were detected by enhanced chemiluminescence (ECL) substrate (Pierce). Original images of immunoblots used in this study can be found in Supplementary Figure 8 .
To detect Plk4 coimmunoprecipitated with Cep192 or Cep152 at endogenous levels, anti-Cep192 or anti-Cep152 antibodies were first cross-linked to protein A/G-agarose beads with Pierce Crosslink IP Kit (Thermo Scientific) and then used for immunoprecipitation analysis with HeLa lysates prepared in the TBSN buffer.
For lambda phosphatase (λ-PPase)-treated experiments, cell lysates were prepared in a phosphatase lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% Nonidet P-40, 1 mM EDTA, 1 mM MgCl 2 and 2 mM MnCl 2 ), incubated with 2,000 units of λ-phosphatase (New England BioLabs) for 1 h at 30 °C, and then subjected to coimmunoprecipitation analysis with the indicated antibodies.
In vitro kinase reaction. For the Plk4 kinase assay in Supplementary Figure 7b , HEK293T cells individually transfected with control vector (−), Flag-Plk4 (WT or K41M mutant), GFP-Cep192 or GFP-Cep152 were lysed, and the resulting lysates were mixed before immunoprecipitation with anti-Flag-M2 bead (Sigma). Kinase assays were performed essentially as described previously 32 in a buffer containing 100 µM ATP (5 µCi of [γ-32 P]ATP; 1 Ci = 37 GBq) for 30 min at 30 °C. Bacterially expressed His 6 -Cep192(201-310) fragment was included as an in vitro substrate. Half of each sample was separated by 10% SDS-PAGE, stained with Coomassie brilliant blue (CBB) and then autoradiographed. The other half of each sample was transferred to PVDF and immunoblotted with anti-p-S305 antibody 33 .
